338 related articles for article (PubMed ID: 35961417)
1. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
[TBL] [Abstract][Full Text] [Related]
2. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
Dilnawaz F
Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
6. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
7. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
Djayanti K; Maharjan P; Cho KH; Jeong S; Kim MS; Shin MC; Min KA
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047329
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
10. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
Hu JJ; Xiao D; Zhang XZ
Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
[TBL] [Abstract][Full Text] [Related]
11. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
[TBL] [Abstract][Full Text] [Related]
15. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
16. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
Kolimi P; Narala S; Youssef AAA; Nyavanandi D; Dudhipala N
Nanotheranostics; 2023; 7(1):70-89. PubMed ID: 36593800
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
18. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
Sarkar S; Ekbal Kabir M; Kalita J; Manna P
Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
[TBL] [Abstract][Full Text] [Related]
20. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
